Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06183905 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multi-parametric Ultrasound Versus Multi-parametric MRI for Prostate Cancer Detection

Study acronym: TRUSVSMPMRI
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Active, Not Recruitingv2 Show 6 more changesShow less
    • Enrollment target: estimated 500 to confirmed 635
    • Primary completion date changed from estimate of Dec 31, 2025 to Jun 30, 2025
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    • Start date changed from estimate of Dec 2023 to Dec 29, 2023
    • Secondary endpoints: details revised at 2 of 2 entries
    • Site contact updated
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this cohort study is to investigate multiparametric ultrasound versus multiparametric MRI for clinically significant prostate cancer detection in patients scheduled for initial biopsy. The main questions it aims to answer are: * whether the clinically significant prostate cancer detection rate of multiparametric ultrasound is comparable to multiparametric MRI * the any cancer detection of multiparametric ultrasound versus multiparametric MRI Participants will undergo multiparametric ultrasound and multiparametric MRI before prostate biopsy. In case of suspicious findings on ultrasound or MRI, they will undergo combined systematic biopsy and targeted biopsy. In case of nonsuspicious imaging finding, they will undergo systematic biopsy alone.
Trial Details
NCT Number NCT06183905
Lead Sponsor Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Conditions
(from sponsor)		 PROSTATE CANCER, Prostate Biopsy
Related terms Prostatic Neoplasms
Enrollment 635 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov